ChemicalBook
English   Japanese   Germany   Korea

网站主页 >> CAS数据库列表 >> 3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮

3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮

生物活性 靶点 体外研究 体内研究 3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮 试剂级价格
3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮, 893422-47-4, 结构式
3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮
CAS号:
893422-47-4
英文名:
3-Phenyl-2-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-1,6-Naphthyridin-5(6H)-one
英文别名:
Akti_2008;Akt1Akt2-IN-17;Akt1/Akt2-IN-1;Akt1/2 inhibitor 1;Akt1 and Akt2-IN-1;Akt-1 and Akt2-IN-1,Akt1 and Akt2IN1,Akt1 and Akt2 IN 1;3-Phenyl-2-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-1,6-Naphthyridin-5(6H)-one;3-phenyl-2-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-1,6-naphthyridin-5(6H)-one;1,6-Naphthyridin-5(6H)-one, 3-phenyl-2-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-
中文名:
3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮
中文别名:
化合物 T14152;AKT1变构抑制剂(AKT1 AND AKT2-IN-1);3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮
CBNumber:
CB62473868
分子式:
C33H29N7O
分子量:
539.63
MOL File:
893422-47-4.mol

3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮化学性质

密度:
1.285±0.06 g/cm3(Predicted)
储存条件:
Store at -20°C
溶解度:
DMSO : ≥ 35 mg/mL (64.86 mM)
酸度系数(pKa):
7.99±0.40(Predicted)
安全信息

3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮性质、用途与生产工艺

生物活性

Akt1 and Akt2-IN-1 是一种有效的变构抑制剂, 抑制 Akt1 (IC50=3.5 nM) 和 Akt2 (IC50=42 nM)。

靶点

Akt1

3.5 nM (IC 50 )

Akt2

42 nM (IC 50 )

体外研究

Consistent with the allosteric mode of inhibition, Akt1 and Akt2-IN-1 (Compound 17) is dependent on the PH-domain for Akt inhibition, is selective for Akt1/2 over Akt3 (IC 50 =1900 nM), and is highly selective over other members of the AGC family of kinases (>50 μM vs PKA, PKC, SGK). Akt1 and Akt2-IN-1 (Compound 17) has moderate activity in an hERG binding assay (IC 50 =5610 nM) and is a substrate for human P-glycoprotein.

体内研究

Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in at exposures that provide high levels of Akt1 and 2 inhibition in vivo. Akt1 and Akt2-IN-1 (Compound 17) has also been shown to inhibit the growth of A2780 tumors in vivo when used as monotherapy. Akt1 and Akt2-IN-1 (Compound 17) has potent inhibitory activity against Akt1 and 2 in vivo in a mouse lung and efficacy in a tumor xenograft model. Akt1 and Akt2-IN-1 (Compound 17) shows good pharmacokinetics in rat with a low clearance of 4.6 mL/min/kg and a half-life of 3.8 h. Due to the improved cell potency, physical properties, and rodent pharmacokinetics of Akt1 and Akt2-IN-1 (Compound 17), tolerability and Akt inhibition are assessed in mice. Using an acute dosing schedule (IP dosing of 50 mg/kg at times 0, 3, and 8 h), administration of Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in mice and shows high levels of Akt inhibition in mouse lung.

3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮 上下游产品信息

上游原料

下游产品

3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮 试剂级价格

更新日期产品编号产品名称CAS编号包装价格
2024/04/30HY-50862Akt1/Akt2-IN-11 mg1590元
2024/04/30HY-508623-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮
Akt1 and Akt2-IN-1		893422-47-45mg2800元

3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮 生产厂家

全球有 30家供应商   3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮国内生产厂家
供应商联系电话电子邮件国家产品数优势度
上海皓元医药股份有限公司 021-58950125 info@chemexpress.com 中国 7553 61
上海复青化学科技有限公司 13816107857 sales@fortunechem-sh.com 中国 289 58
MedChemexpress LLC 021-58955995 sales@medchemexpress.cn 美国 4863 58
上海喀露蓝科技有限公司 18149758185 sales-cpd@caerulumpharma.com 中国 3427 58
四川省维克奇生物科技有限公司 028-81700200 18116577057 3003855609@qq.com 中国 7892 56
上海源叶生物科技有限公司 021-61312847; 18021002903 3008007409@qq.com 中国 27322 60
Musechem +1-800-259-7612 info@musechem.com 美国 4662 60
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 marketing@targetmol.com 美国 19892 58
上海源溪生物科技有限公司 021-58447131 13564518121 sales@dcchemicals.com 中国 9414 58
常州辰鸿生物科技有限公司 0519-85788828 13775037613 sales@chemrenpharm.com 中国 3574 58
北京新研汇医药研发有限公司 13969155946 1461866103@qq.com 中国 16111 58
ChemeGen 中国 18818260767 sales@chemegen.com 中国 11289 58
上海泽叶生物科技有限公司 021-61998551 13122364865 sale1@shzysw.net 中国 9771 58
爱必信（上海）生物科技有限公司 021-38015121 15000105423 chenjw@absin.cn 中国 24734 58
上海博拓生物科技有限公司 16621358918 botuopharma888@163.com 中国 9215 58
深圳市凯米克生物科技有限公司 18964309092 18964309092 2769493375@qq.com 中国 2635 58
天津普西唐生物医药科技有限公司 010-60605840 psaitong@jm-bio.com 中国 29778 58
TargetMol中国（陶术生物） 4008200310 marketing@tsbiochem.com 中国 24017 58
嘉兴市浙嘉生物科技有限公司 0573-85609002 18157336032 zhejia01@163.com 中国 7859 58
上海陌孚医药科技有限公司 021-59167510 18117107507 vip@med-life.cn 中国 5019 58
南京世洲生物科技有限公司 025-85560043 15850508050 cindy.huang@synzest.com 中国 12007 58
銳迪國際科技有限公司 18024082417 market@ubiochem.com 中国 9180 58
Aladdin Scientific +1-+1(833)-552-7181 sales@aladdinsci.com 美国 52927 58
 

893422-47-4, 3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮 相关搜索:

Phenylimidazole 2-苯基吡啶 吡啶 2,6-二甲基吡啶
  • 对照品
  • 细胞生物学试剂
  • C33H29N7O
  • 化合物 T14152
  • AKT1变构抑制剂(AKT1 AND AKT2-IN-1)
  • 3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮
  • 893422-47-4
  • Akt1/Akt2-IN-1
  • Akt-1 and Akt2-IN-1,Akt1 and Akt2IN1,Akt1 and Akt2 IN 1
  • 1,6-Naphthyridin-5(6H)-one, 3-phenyl-2-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-
  • Akt1/2 inhibitor 1
  • Akt1Akt2-IN-17
  • 3-phenyl-2-(4-((4-(5-(pyridin-2-yl)-1H-1,2,4-triazol-3-yl)piperidin-1-yl)methyl)phenyl)-1,6-naphthyridin-5(6H)-one
  • Akt1 and Akt2-IN-1
  • Akti_2008
  • 3-Phenyl-2-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1-piperidinyl]methyl]phenyl]-1,6-Naphthyridin-5(6H)-one
Copyright 2016 © ChemicalBook. All rights reserved